Europe Generic Drugs Market Growth, Size, Share, Industry Report and Forecast 2020-2026

Europe generic drugs market is estimated to grow at a CAGR of nearly 5.7% during the forecast period. European government initiatives to support generic producers are supporting to drive market growth. In May 2019, the European Union (EU) is taking measures to increase the competitiveness of EU manufacturers of generic drugs and biosimilar products. EU-based producers of generics and biosimilars will be entitled to produce a biosimilar or a generic version of a supplementary protection certificate (SPC)-protected drug. The new EU regulation will allow manufacturers of generic drugs that are EU based to compete with non-EU manufacturers equally. This will generate high-value jobs and increase the accessibility of generic medicines within the EU.

To Request a Sample of our Report on Europe Generic Drugs Market:  https://www.omrglobal.com/request-sample/europe-generic-drugs-market

Additionally, in November 2020, the European Commission makes a draft that intends to make it easier for patients to gain access to low-cost, generic medicines. This draft could cut the revenues of major pharma companies. The European Commission will consider targeted policies that facilitate higher competition in generic and biosimilar. Removal of barriers that delays the entry of generic medicines is also expected to witness by 2022. Such kinds of initiatives will further escalate market growth.

 (Get 15% Discount on Buying this Report)

A full Report of Europe Generic Drugs Market is Available at:  https://www.omrglobal.com/industry-reports/europe-generic-drugs-market

 Scope of the Europe Generic Drugs Market

 Market Coverage

·        Market number available for 2019-2026

·        Base year- 2019

·        Forecast period- 2020-2026

·        Segment Covered- By Application and Route of Administration

·        Countries Covered- UK, Germany, France, Spain, Italy, and Rest of Europe

·        Competitive Landscape- Mylan N.V., Teva Pharmaceutical Industries Ltd., Lupin Ltd., and Novartis International AG

Recent Strategic Initiatives in the Europe Generic Drugs Market

·        In November 2020, the European Medicine Agency’s (EMA) declared that it recommends granting marketing authorization for the generic drug Lenalidomide Mylan (lenalidomide). This hard capsule is indicated to treat follicular lymphoma and multiple myeloma. It is a generic version of Celgene’s Revlimid, approved in the European Union (EU) since 2007. 

·        In July 2019, Sandoz, a part of Novartis International AG declared the introduction of the generic cancer drug gefitinib which is intended for adult patients suffering from locally advanced or metastatic non-small cell lung cancer. It is available in 13 countries across Europe and the company will constantly widen to other countries through a phased rollout.

Europe Generic Drugs Market-Segmentation

 By Application

·        Cancer

·        CVD

·        Musculoskeletal Diseases

·        Infectious Diseases

·        Neurology

·        Diabetes

·        Others

By Route of Administration

·        Oral

·        Topical

·        Injectable

·        Inhaler

Europe Generic Drugs Market– Segment by Country 

·        Germany

·        UK

·        France

·        Spain

·        Italy

Rest of Europe

Company Profiles

·        Alvion Pharmaceuticals P.C

·        Fresenius SE & Co. KGaA

·        GlaxoSmithKline plc

·        Hikma Pharmaceuticals PLC

·        Lupin Ltd.

·        Mylan N.V.

·        Novartis International AG

·        Novo Nordisk A/S

·        StadaArzneimittel AG

·        Teva Pharmaceutical Industries Ltd.

Reasons to Buying From us –

1.  We cover more than 15 major industries, further segmented into more than 90 sectors.

2.  More than 120 countries are for analysis.

3.  Over 100+ paid data sources mined for investigation.

4.  Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @  https://www.omrglobal.com/report-customization/europe-generic-drugs-market

About Orion Market Research 

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit Orion Market Research

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no:  +91 7803040404

Comments

Post a Comment

Popular posts from this blog

European Data Backup and Recovery Market Size, Share, Analysis, Industry Report and Forecast 2019-2025

  European Data Backup and Recovery Market are expected to reach $5.7 billion in 2027, growing at a CAGR of 9.5% during the forecast period (2021-2027). Factors responsible for the growth of the market in Europe are well-developed telecommunication infrastructure, high internet penetration, high adoption of cloud-based devices among people and organization. Regulations regarding the data localization such as GDPR by the European Union and countries own data localization and protection act are providing growth to the market. Major economies which are expected to hold a considerable market are UK, Germany, France, Italy, and Spain. These economies are part of the European Union, which covers most of the continent. The aim of the European Union was to increase economic cooperation and encourage free trade among countries. To Request a Sample of our Report on European Data Backup and Recovery Market :   https://www.omrglobal.com/request-sample/european-data-backup-recovery-...
Read more

Insect Repellent Market Is Likely to Experience a Tremendous Growth by 2031

This informative Insect Repellent Market report provides new method and covers foremost regions such as Latin America, Middle East, North America, Europe, Africa and Asia Pacific. Making most out of the consumer insights and market opportunities, market players can boost up the revenue rate of their business. It also permits key organizations to make communication with customers and know their demands for making right investment in the product development. By increasing the product portfolio by referring the important market data provided in this Insect Repellent Market research report, key players can grow and expand their business forward. Continuously developing customer demands are also described in this global report to help new entrants make required changes in the final product launch and then bring into the market. It becomes easy for key players to prioritize the demands and requirements of target audience and have complete understanding of end-user experience with the help o...
Read more

Asia-Pacific Urban Air Mobility Market Growth, Size, Share, Industry Report and Forecast 2019-2025

The Asia-Pacific urban air mobility market is estimated to grow at a CAGR of 12.6% during the forecast period. The Asia-Pacific urban air mobility market is segmented on the basis of component and operation. Based on the component, the market is further segmented into infrastructure and platform. The infrastructure segment is further segmented into charging stations, traffic management, and others whereas, the platform segment is further classified into air taxi, personal air vehicle, air ambulance, and others. The platform segment dominated the global urban air mobility market. To Request a Sample of our Report on Asia-Pacific Urban Air Mobility Market :   https://www.omrglobal.com/request-sample/asia-pacific-urban-air-mobility-market Asia-Pacific is home to several emerging economies and is seen as the potential market for the UAM owing to growing urbanization coupled with increasing traffic congestion and increasing high-income groups in the region. The growth of the As...
Read more